\-\ Texto\\:\\ \ \(0\)\
\-\ vs\\:\\ t\\ 98\\.3\\,\\ b\\/p\\ 97\\/59\\,\\ p\\ 71\\,\\ r\\ 18\\,\\ o2\\ sat\\ 99\\%\\ on\\ ra\\,\\ no\\ pain\ \(0\)\
\-\ gen\\:\\ wd\\/wn\\,\\ alert\\ and\\ cooperative\\ in\\ nad\\.\\ no\\ weight\\ loss\\,\\ nervousness\\,\\ emotional\\ lability\\,\\ fatique\\,\\ tremor\\,\\ palpitations\\,\\ excessive\\ appetite\\;\\ no\\ increased\\ perspiration\\,\\ heat\\ intolerance\\,\\ moist\\/smooth\\/warm\\ skin\\.\ \(0\)\
\-\ heent\\:\\ nc\\/at\\,\\ perrla\\,\\ eomi\\,\\ tm\\ wnl\\,\\ mmm\\,\\ throat\\ pink\\ no\\ hoarseness\\ or\\ stridor\ \(0\)\
\-\ neck\\:\\ \\ mass\\ was\\ located\\ anterior\\,\\ midline\\;\\ non\\-mobile\\,\\ smooth\\,\\ firm\\ and\\ non\\-tender\\.\\ measurements\\:\\ neck\\ girth\\ 41cm\\/diagonal\\ r\\ to\\ l\\ 11\\.5cm\\/diagonal\\ l\\ to\\ r\\ 12cm\\/width\\ 14\\ cm\\ and\\ length\\ 9\\.5cm\\ \ \(0\)\
\-\ chest\\:\\ symmetric\\,\\ no\\ mass\\.\ \(0\)\
\-\ resp\\:\\ cta\\ b\\ no\\ w\\/r\\/r\ \(0\)\
\-\ cv\\:\\ s1s2\\,\\ rrr\\,\\ no\\ murmur\ \(0\)\
\-\ abd\\:\\ soft\\,\\ nt\\/nt\\,\\ no\\ hsm\ \(0\)\
\-\ gu\\:\\ tanner\\ ii\ \(0\)\
\-\ ext\\:\\ cr\\<2sec\ \(0\)\
\-\ neuro\\:\\ a\\/ox3\\,\\ cn\\ ii\\-xii\\ grossly\\ intact\\,\\ good\\ muscle\\ strength\\,\\ reflexes\\ 2\\+\\ ue\\/le\ \(0\)\
\-\ labs\ \(154\)\
\-\ cbc\\:\\ wbc\\ 11\\.1\\/hg\\ 12\\.8\\/htc\\ 37\\.0\\/plt\\ 359\\ \\ n61\\/b0\\/l28\ \(0\)\
\-\ esr\\:\\ 40\ \(0\)\
\-\ ca\\.\\ 9\\.4\\/phos\\.\\ 4\\/3\\/pt\\ 10\\.7\\/inr\\ 1\\.01\\/\\ ptt\\ 31\\.2\ \(0\)\
\-\ free\\ t\\:\\ 1\\.09\ \(0\)\
\-\ tt4\\:\\ 105\ \(0\)\
\-\ tt3\\:\\ 186\ \(0\)\
\-\ tsh\\:\\ 2\\.33\ \(0\)\
\-\ antimicrosomal\\ \\(ama\\)\\:\\ \\>1000\ \(0\)\
\-\ antithyroglobulin\\ \\(ata\\)\\:\\ \\>1000\ \(0\)\
\-\ thyroxin\\ binding\\ globulin\\:\\ 25\ \(0\)\
\-\ neck\\ biopsy\\:\\ papillary\\ thyroid\\ carcinoma\ \(0\)\
\-\ treatment\\ consists\\ of\\ total\\ or\\ near\\-total\\ thyroidectomy\\ and\\ removal\\ of\\ all\\ involved\\ lymph\\ nodes\\.\\ this\\ is\\ usually\\ followed\\ by\\ radioiodine\\ ablation\\ to\\ destroy\\ the\\ residual\\ thyroid\\ remnant\\ and\\ any\\ metastatic\\ tissue\\ left\\ behind\\ after\\ surgery\\.\\ thyroid\\ replacement\\ is\\ then\\ started\\ to\\ suppress\\ tsh\\ and\\ prevent\\ stimulation\\ of\\ residual\\ thyroid\\ tissue\\.\\ since\\ papillary\\ thyroid\\ carcinoma\\ in\\ children\\ is\\ associated\\ with\\ a\\ high\\ rate\\ of\\ recurrence\\ regular\\ interval\\ follow\\-up\\ with\\ serum\\ thyroglobulin\\ levels\\ \\(a\\ tumor\\ marker\\)\\ and\\ radioiodine\\ whole\\ body\\ scans\\ are\\ required\\.\ \(0\)\
\-\ papillary\\ thyroid\\ carcinoma\ \(4\)\
\-\ thyroid\\ neoplasia\ \(0\)\
\-\ \\ \\-\\ benign\ \(2\)\
\-\ \\ \\ \\ \\ \\ \\-\\ adenoma\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ colloid\\ nodule\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ teratoma\\ \\(newborn\\)\ \(0\)\
\-\ \\ \\-\\ malignant\ \(1\)\
\-\ \\ \\ \\ \\ \\ \\-\\ papillary\\ adenocarcinoma\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ follicular\\ carcinoma\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ mixed\\ papillary\\ and\\ follicular\\ carcinoma\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\-\\ other\\:\\ anaplastic\\,\\ hurthe\\ cell\\,\\ lymphoma\\,\\ sacroma\\,\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ epithelial\\,\\ metastatic\\ medullary\\ thyroid\\ carcinoma\ \(1\)\
\-\ 11\\ y\\/o\\ girl\\,\\ previously\\ healthy\\,\\ admitted\\ to\\ the\\ pediatric\\ ward\\ for\\ evaluation\\ of\\ large\\ neck\\ mass\\.\\ mother\\ noticed\\ a\\ midline\\ anterior\\ neck\\ mass\\ 8\\ days\\ prior\\ ot\\ admit\\.\\ no\\ fever\\,\\ swelling\\,\\ pain\\ or\\ erythema\\.\\ no\\ change\\ in\\ size\\ or\\ shape\\.\\ no\\ history\\ of\\ acute\\ illness\\ or\\ trauma\\.\\ no\\ exposure\\ to\\ radiation\\.\\ no\\ symptoms\\ of\\ hyper\\-\\ or\\ hypothyroidism\\ and\\ no\\ family\\ history\\ of\\ thyroid\\ disease\\ or\\ tumor\\ syndromes\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroid\\:\\ 0\\.34378835474556274\ \(0\)\
\-\ papillary\\:\\ 0\\.22647916459495862\ \(0\)\
\-\ no\\:\\ 0\\.22128681775493414\ \(0\)\
\-\ carcinoma\\:\\ 0\\.17444439123390762\ \(0\)\
\-\ neck\\:\\ 0\\.14866896376006186\ \(0\)\
\-\ radioiodine\\:\\ 0\\.1298318134267703\ \(0\)\
\-\ or\\:\\ 0\\.11836475593490788\ \(0\)\
\-\ 1000\\:\\ 0\\.11622382128537041\ \(0\)\
\-\ follicular\\:\\ 0\\.11110950497382359\ \(0\)\
\-\ 11\\:\\ 0\\.10916510799691774\ \(0\)\
\-\ tsh\\:\\ 0\\.09392750177277837\ \(0\)\
\-\ and\\:\\ 0\\.09039498885938785\ \(0\)\
\-\ residual\\:\\ 0\\.08845866314586347\ \(0\)\
\-\ smooth\\:\\ 0\\.08026203308594487\ \(0\)\
\-\ total\\:\\ 0\\.07965333339568863\ \(0\)\
\-\ fatique\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ perspiration\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ tt4\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ tt3\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ antimicrosomal\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ antithyroglobulin\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ ata\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ thyroxin\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ globulin\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ hurthe\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ sacroma\\:\\ 0\\.07773198443707864\ \(0\)\
\-\ ii\\:\\ 0\\.07664620168735697\ \(0\)\
\-\ of\\:\\ 0\\.07609623275264836\ \(0\)\
\-\ lability\\:\\ 0\\.07427706093985853\ \(0\)\
\-\ 2sec\\:\\ 0\\.07427706093985853\ \(0\)\
\-\ mass\\:\\ 0\\.07426516845126625\ \(0\)\
\-\ midline\\:\\ 0\\.07311287933681439\ \(0\)\
\-\ to\\:\\ 0\\.07290881064878221\ \(0\)\
\-\ emotional\\:\\ 0\\.0699243721011917\ \(0\)\
\-\ 359\\:\\ 0\\.0699243721011917\ \(0\)\
\-\ destroy\\:\\ 0\\.0699243721011917\ \(0\)\
\-\ s1s2\\:\\ 0\\.06837083021060528\ \(0\)\
\-\ binding\\:\\ 0\\.06837083021060528\ \(0\)\
\-\ ot\\:\\ 0\\.06705732925775491\ \(0\)\
\-\ admit\\:\\ 0\\.06591952297857215\ \(0\)\
\-\ thyroglobulin\\:\\ 0\\.06491590671338515\ \(0\)\
\-\ nervousness\\:\\ 0\\.06401814137193845\ \(0\)\
\-\ 186\\:\\ 0\\.06401814137193845\ \(0\)\
\-\ suppress\\:\\ 0\\.06401814137193845\ \(0\)\
\-\ cooperative\\:\\ 0\\.06320601383458599\ \(0\)\
\-\ mmm\\:\\ 0\\.06246459948135203\ \(0\)\
\-\ ama\\:\\ 0\\.06246459948135203\ \(0\)\
\-\ hsm\\:\\ 0\\.06178256439129774\ \(0\)\
\-\ tanner\\:\\ 0\\.06178256439129774\ \(0\)\
\-\ remnant\\:\\ 0\\.06115109852850167\ \(0\)\
\-\ tremor\\:\\ 0\\.05900967598413191\ \(0\)\
\-\ girth\\:\\ 0\\.05900967598413191\ \(0\)\
\-\ ward\\:\\ 0\\.05900967598413191\ \(0\)\
\-\ neoplasia\\:\\ 0\\.05854897515079104\ \(0\)\
\-\ thyroidectomy\\:\\ 0\\.05769617503128155\ \(0\)\
\-\ palpitations\\:\\ 0\\.05692101453578704\ \(0\)\
\-\ tm\\:\\ 0\\.05692101453578704\ \(0\)\
\-\ hoarseness\\:\\ 0\\.05692101453578704\ \(0\)\
\-\ stridor\\:\\ 0\\.05692101453578704\ \(0\)\
\-\ measurements\\:\\ 0\\.056558368752098784\ \(0\)\
\-\ resp\\:\\ 0\\.055876333662044496\ \(0\)\
\-\ gu\\:\\ 0\\.055876333662044496\ \(0\)\
\-\ pink\\:\\ 0\\.055554752486911795\ \(0\)\
\-\ ptt\\:\\ 0\\.055554752486911795\ \(0\)\
\-\ perrla\\:\\ 0\\.05524486779924842\ \(0\)\
\-\ marker\\:\\ 0\\.05524486779924842\ \(0\)\
\-\ anterior\\:\\ 0\\.05427778569677733\ \(0\)\
\-\ 105\\:\\ 0\\.054107061520065655\ \(0\)\
\-\ heat\\:\\ 0\\.05384485960811262\ \(0\)\
\-\ intolerance\\:\\ 0\\.0535904857994051\ \(0\)\
\-\ stimulation\\:\\ 0\\.0535904857994051\ \(0\)\
\-\ anaplastic\\:\\ 0\\.053343486192614725\ \(0\)\
\-\ metastatic\\:\\ 0\\.053316199497621314\ \(0\)\
\-\ ablation\\:\\ 0\\.053103445254878666\ \(0\)\
\-\ eomi\\:\\ 0\\.052869981615642436\ \(0\)\
\-\ excessive\\:\\ 0\\.05242141016482438\ \(0\)\
\-\ epithelial\\:\\ 0\\.05220567991343196\ \(0\)\
\-\ ext\\:\\ 0\\.05199527688308423\ \(0\)\
\-\ appetite\\:\\ 0\\.051014783806533785\ \(0\)\
\-\ whole\\:\\ 0\\.051014783806533785\ \(0\)\
\-\ tissue\\:\\ 0\\.05099549231373132\ \(0\)\
\-\ tumor\\:\\ 0\\.05084778365713519\ \(0\)\
\-\ colloid\\:\\ 0\\.050831531802185914\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.05065213802284553\ \(0\)\
\-\ cr\\:\\ 0\\.050304298306798265\ \(0\)\
\-\ o2\\:\\ 0\\.05013556230218498\ \(0\)\
\-\ syndromes\\:\\ 0\\.04997010293279125\ \(0\)\
\-\ sat\\:\\ 0\\.04889396801896295\ \(0\)\
\-\ illness\\:\\ 0\\.04889396801896295\ \(0\)\
\-\ throat\\:\\ 0\\.048750756416211835\ \(0\)\
\-\ nad\\:\\ 0\\.04833502080480818\ \(0\)\
\-\ cv\\:\\ 0\\.04833502080480818\ \(0\)\
\-\ consists\\:\\ 0\\.04833502080480818\ \(0\)\
\-\ noticed\\:\\ 0\\.0482008307908124\ \(0\)\
\-\ ra\\:\\ 0\\.048068721326157554\ \(0\)\
\-\ gen\\:\\ 0\\.04793862887885937\ \(0\)\
\-\ newborn\\:\\ 0\\.04793862887885937\ \(0\)\
\-\ 99\\:\\ 0\\.04768425507015185\ \(0\)\
\-\ cn\\:\\ 0\\.04743725546336147\ \(0\)\
\-\ 71\\:\\ 0\\.04719721452562542\ \(0\)\
\-\ behind\\:\\ 0\\.04684937480957814\ \(0\)\
\-\ grossly\\:\\ 0\\.04662512792600901\ \(0\)\
\-\ exposure\\:\\ 0\\.04619359826043843\ \(0\)\
\-\ murmur\\:\\ 0\\.04608904615383098\ \(0\)\
\-\ shape\\:\\ 0\\.04608904615383098\ \(0\)\
\-\ cta\\:\\ 0\\.045782873463518156\ \(0\)\
\-\ wnl\\:\\ 0\\.04558470430430779\ \(0\)\
\-\ rrr\\:\\ 0\\.045295832918991724\ \(0\)\
\-\ neuro\\:\\ 0\\.045295832918991724\ \(0\)\
\-\ abd\\:\\ 0\\.04520167848272077\ \(0\)\
\-\ alert\\:\\ 0\\.04474590729359229\ \(0\)\
\-\ prevent\\:\\ 0\\.044570212619924686\ \(0\)\
\-\ esr\\:\\ 0\\.044483705381639246\ \(0\)\
\-\ length\\:\\ 0\\.04431328190503641\ \(0\)\
\-\ firm\\:\\ 0\\.044063872203537996\ \(0\)\
\-\ interval\\:\\ 0\\.043982331966141354\ \(0\)\
\-\ erythema\\:\\ 0\\.043982331966141354\ \(0\)\
\-\ replacement\\:\\ 0\\.04366375692608426\ \(0\)\
\-\ serum\\:\\ 0\\.04358594004019255\ \(0\)\
\-\ pediatric\\:\\ 0\\.043508827389169065\ \(0\)\
\-\ heent\\:\\ 0\\.04343240634074192\ \(0\)\
\-\ medullary\\:\\ 0\\.042987737289709706\ \(0\)\
\-\ reflexes\\:\\ 0\\.04249668597091132\ \(0\)\
\-\ scans\\:\\ 0\\.04229460006155916\ \(0\)\
\-\ teratoma\\:\\ 0\\.04203239814960612\ \(0\)\
\-\ regular\\:\\ 0\\.04196808924221407\ \(0\)\
\-\ symmetric\\:\\ 0\\.04165362958006042\ \(0\)\
\-\ mother\\:\\ 0\\.041531024734108225\ \(0\)\
\-\ ca\\:\\ 0\\.04147037757571256\ \(0\)\
\-\ nodes\\:\\ 0\\.04129098379637217\ \(0\)\
\-\ healthy\\:\\ 0\\.04123201546564096\ \(0\)\
\-\ started\\:\\ 0\\.04094314408032489\ \(0\)\
\-\ strength\\:\\ 0\\.040718897196755754\ \(0\)\
\-\ cbc\\:\\ 0\\.04055450194097982\ \(0\)\
\-\ mixed\\:\\ 0\\.040234931120883805\ \(0\)\
\-\ recurrence\\:\\ 0\\.040131016542972436\ \(0\)\
\-\ is\\:\\ 0\\.039933460043573024\ \(0\)\
\-\ children\\:\\ 0\\.039826666697844314\ \(0\)\
\-\ admitted\\:\\ 0\\.039826666697844314\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.03972758546769026\ \(0\)\
\-\ good\\:\\ 0\\.03953281379248959\ \(0\)\
\-\ previously\\:\\ 0\\.03901907034367943\ \(0\)\
\-\ involved\\:\\ 0\\.03897386657833482\ \(0\)\
\-\ adenoma\\:\\ 0\\.03875137639815989\ \(0\)\
\-\ levels\\:\\ 0\\.038534548164705064\ \(0\)\
\-\ located\\:\\ 0\\.03844933855678587\ \(0\)\
\-\ nodule\\:\\ 0\\.03836497262220418\ \(0\)\
\-\ family\\:\\ 0\\.03823996955226107\ \(0\)\
\-\ free\\:\\ 0\\.03783606029915205\ \(0\)\
\-\ lymph\\:\\ 0\\.03779670277059489\ \(0\)\
\-\ removal\\:\\ 0\\.03715402520909777\ \(0\)\
\-\ history\\:\\ 0\\.037140807038611424\ \(0\)\
\-\ vs\\:\\ 0\\.03708150656045646\ \(0\)\
\-\ 18\\:\\ 0\\.036832444033965066\ \(0\)\
\-\ rate\\:\\ 0\\.036832444033965066\ \(0\)\
\-\ change\\:\\ 0\\.036832444033965066\ \(0\)\
\-\ 14\\:\\ 0\\.036289095707065455\ \(0\)\
\-\ in\\:\\ 0\\.03627497681688412\ \(0\)\
\-\ skin\\:\\ 0\\.036158504801796235\ \(0\)\
\-\ 40\\:\\ 0\\.03574739885080717\ \(0\)\
\-\ since\\:\\ 0\\.03520905839345132\ \(0\)\
\-\ intact\\:\\ 0\\.035180124953822764\ \(0\)\
\-\ pain\\:\\ 0\\.03478621410916174\ \(0\)\
\-\ required\\:\\ 0\\.03470271797706464\ \(0\)\
\-\ malignant\\:\\ 0\\.034648271211726575\ \(0\)\
\-\ muscle\\:\\ 0\\.03451365719903525\ \(0\)\
\-\ 25\\:\\ 0\\.034433897897956804\ \(0\)\
\-\ then\\:\\ 0\\.034407476513117506\ \(0\)\
\-\ wbc\\:\\ 0\\.03435487826101736\ \(0\)\
\-\ girl\\:\\ 0\\.03409664971811904\ \(0\)\
\-\ biopsy\\:\\ 0\\.034071252114268556\ \(0\)\
\-\ weight\\:\\ 0\\.03389555744060096\ \(0\)\
\-\ labs\\:\\ 0\\.03367486018831974\ \(0\)\
\-\ benign\\:\\ 0\\.033389217024214275\ \(0\)\
\-\ fever\\:\\ 0\\.03295566459548086\ \(0\)\
\-\ size\\:\\ 0\\.03291128486086881\ \(0\)\
\-\ followed\\:\\ 0\\.03282321286456164\ \(0\)\
\-\ swelling\\:\\ 0\\.032714387761044766\ \(0\)\
\-\ radiation\\:\\ 0\\.03221054308979189\ \(0\)\
\-\ body\\:\\ 0\\.03198920883307847\ \(0\)\
\-\ any\\:\\ 0\\.03141325384923825\ \(0\)\
\-\ days\\:\\ 0\\.03076986231649906\ \(0\)\
\-\ usually\\:\\ 0\\.030599438839896218\ \(0\)\
\-\ evaluation\\:\\ 0\\.029642821534368587\ \(0\)\
\-\ loss\\:\\ 0\\.02961271235186145\ \(0\)\
\-\ lymphoma\\:\\ 0\\.02894803495732564\ \(0\)\
\-\ all\\:\\ 0\\.02893414597334843\ \(0\)\
\-\ trauma\\:\\ 0\\.028228657900236296\ \(0\)\
\-\ cm\\:\\ 0\\.02791512400918376\ \(0\)\
\-\ cell\\:\\ 0\\.027805017655791017\ \(0\)\
\-\ high\\:\\ 0\\.027624610992076963\ \(0\)\
\-\ prior\\:\\ 0\\.02719528544193383\ \(0\)\
\-\ symptoms\\:\\ 0\\.026594589717276663\ \(0\)\
\-\ acute\\:\\ 0\\.02629412599975177\ \(0\)\
\-\ increased\\:\\ 0\\.02628395180178664\ \(0\)\
\-\ surgery\\:\\ 0\\.026132778887219137\ \(0\)\
\-\ soft\\:\\ 0\\.025876936187511163\ \(0\)\
\-\ chest\\:\\ 0\\.02565684482208507\ \(0\)\
\-\ associated\\:\\ 0\\.025619141708431152\ \(0\)\
\-\ other\\:\\ 0\\.025242008940346308\ \(0\)\
\-\ large\\:\\ 0\\.02435414690051814\ \(0\)\
\-\ after\\:\\ 0\\.0235796914265186\ \(0\)\
\-\ treatment\\:\\ 0\\.023153738708446635\ \(0\)\
\-\ by\\:\\ 0\\.020641035195877174\ \(0\)\
\-\ disease\\:\\ 0\\.020403179381831366\ \(0\)\
\-\ the\\:\\ 0\\.01939741847754597\ \(0\)\
\-\ with\\:\\ 0\\.019035425058396335\ \(0\)\
\-\ are\\:\\ 0\\.01844386342931765\ \(0\)\
\-\ was\\:\\ 0\\.016939761327249937\ \(0\)\
\-\ this\\:\\ 0\\.01670198477692647\ \(0\)\
\-\ left\\:\\ 0\\.016580653913384823\ \(0\)\
\-\ for\\:\\ 0\\.014732183057655876\ \(0\)\
\-\ on\\:\\ 0\\.014679923526880868\ \(0\)\
